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Abstract 
Background: Methicillin resistant Staphylococcus 
aureus (MRSA) is a common pathogen which has 
increased both morbidity and mortality in hospitals 
and out-door patients.  
Objective: Aim of our study is to measure 
prevalence of MRSA in in-door patients and out-
door patients, as well as its sensitivity against 
gentamycin, vancomycin and ciprofloxacin. 
Methods: A sample of 194 S. aureus was taken 
retrospectively from Pathology lab of a tertiary care 
hospital. MRSA was identified and further subjected 
against gentamycin, vancomycin and ciprofloxacin. 
Result: 65.9% of S. aureus isolates were MRSA. 
22.7%, 35.7%, 99.1% of MRSA were susceptible to 
ciprofloxacin, gentamycin and vancomycin, 
respectively. 75.8% MRSA was from pus samples. 
66% MRSA was from in-door patient department 
(IPD).  
Conclusion: MRSA was more prevalent in IPD. 
MRSA prevalence is escalating. Vancomycin is 
losing its effectiveness against MRSA as one 
resistant case was found. Inappropriate use and 
unprofessional prescriptions for antibiotics can be 
the main cause. Proper legislative action is required 
to keep in control the prescriptions for antibiotics. 
Keywords: Methicillin-Resistant Staphylococcus 
aureus, Bacterial drug resistance, Antimicrobial 
drugs 
 
Introduction 
Staphylococcus aureus discovered in 1880 colonized 
27% of healthy human population in US.1 It causes a 
spectrum of diseases from skin infections like 
abscesses, cellulitis, impetigo, boils and scalded skin 
syndrome to various pyogenic infections like 
endocarditis, septic arthritis and osteomyelitis. It is 
also one of the most common causes of Hospital 
Acquired pneumonia, septicemia and surgical wound 
infections.1 
Penicillin was initially effective against S. aureus but 
resistance against penicillin emerged in penicillinase 
producing strain within 15 years of Penicillin 
discovery.1 In 1961, two years after Methicillin 
introduction, first case of Methicillin resistant 
Staphylococcus aureus (MRSA) was discovered.1 
MRSA poses resistance to almost the entire class of β-
lactam agents1 and is now found worldwide as 
Healthcare Acquired Methicillin resistant 
Staphylococcus aureus (HA-MRSA) & Community 
Acquired Methicillin resistant Staphylococcus aureus 
(CA-MRSA).2 In US hospitals, in 2003, 64% of S. 
aureus isolated in ICU was MRSA.2 During 2003-2004, 
in US, nasal colonization by S. aureus accounted for 
29%, of which MRSA colonized <1.5%.2 MRSA is 
showing remarkable resistance against Ciprofloxacin.2 
43 years after Vancomycin discovery,2 Vancomycin-
intermediate S. aureus (VISA) was identified from 
Japan in 1996.2 There has been a little increase in both 
VISA and Vancomycin-resistant S. aureus (VRSA) 
since then.2 Gentamicin resistance in MRSA is reported 
in up to 72-88% isolates in different European 
hospitals.2 
Summarizing the increasing prevalence in Pakistan: 
MRSA was reported as 5% in 19891 & 61% in 2002.1 In 
another report, prevalence increased from 19.5% to 
40% from 2001 to 2008.4 In Peshawar, there were 207 
cases in 2009, increasing to 284 in 2010 and further 
increasing to 438 in 2011, which showed an increase of 
111.6% in a period of two years from 2009 to 2011.1 
This poses an alarming situation. Prevalence of 
ciprofloxacin resistant MRSA was reported increasing 
from 87% in 1996 to 94% in 2003.5 In a study done in 
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Peshawar, in 2016, ciprofloxacin resistant MRSA 
prevalence was 80.2 %. 
Gentamicin Resistant MRSA strains have been 
increasing steadily in Pakistan from 69% in 1996 to 
88% in 2003.5 VRSA strains were detected in Lahore in 
4% isolates of MRSA in 2004.5  
In Empirical treatment, while vancomycin is the drug 
of choice for MRSA, ciprofloxacin and gentamycin 
(along with β-lactam antibiotics) are still two of the 
most commonly prescribed and used antibiotics in 
Pakistan for indications like respiratory tract 
infections, septicemia, pneumonia, skin infections, 
osteomyelitis, urinary tract infections among many 
others. S. aureus is one of the main pathogens 
associated with these diseases.2 There is very limited 
data available on prevalence and susceptibility 
patterns of MRSA against these drugs in Pakistan 
which is not enough to understand the increasing 
antibiotic resistance in MRSA. Most of the studies 
done in Pakistan to check sensitivity of MRSA against 
these drugs date back to 2003-04. To devise a proper 
health plan and drug regimens for these resistant 
strains, more data is essential. Evaluation and 
gathering data on this topic is becoming imperative to 
prevent any further expansion in infection rates of 
MRSA which would put a huge drain on Pakistan’s 
economy. Thus, it is very much needed and logical to 
conduct studies to gather data and make sense of the 
ever-changing pattern of antimicrobial resistance.  
The objective of the study is to determine the 
prevalence of MRSA isolated from various samples at 
Pathology Lab of Holy Family Hospital, Rawalpindi. 
We have also studied susceptibility pattern of MRSA 
against antimicrobial agents viz. gentamycin, 
ciprofloxacin and vancomycin. Distribution of MRSA 
in OPD and IPD patients is also determined. This 
study will help clinicians to understand and realize the 
alarming rise in antimicrobial resistance and urge 
them to use antibiotics judicially. 
 
Methodology 
This retrospective Cross-Sectional study, was 
conducted at Pathology Lab of Holy Family Hospital 
(HFH), Rawalpindi – a tertiary care hospital. Study 
population were those Out Patient Department (OPD) 
& In-patient Department (IPD) patients at HFH who 
had Staphylococcus aureus identified in their samples. 
Using confidence level 95% and confidence interval 
7%, a sample size of 196 was calculated by WHO 
sample size calculator. A sample of 194 S. aureus 
isolates was collected for a period of 6 months (August 
2017 to January 2018) using consecutive sampling 
technique.  
Various samples from the study population were 
received and transferred to laboratory. MacConkey 
agar and Blood agar were used as culture media for 
growth of bacterial isolates. The samples were 
incubated overnight at 37°C under aerobic conditions. 
Macroscopic features of colonies i.e. yellow to cream 
color, 1-2 mm on Blood agar and 0.1-0.5 mm on 
MacConkey agar, gram positivity and catalase 
positivity were observed to identify Staphylococci. 
Coagulase test differentiated between Coagulase 
Positive S. aureus & Coagulase Negative Staphylococci 
(CoNS). Only S. aureus isolates were included in 
study, all other samples and repeat samples from the 
same patient were excluded.  
The Clinical and Laboratory Standards Institute (CLSI) 
guidelines were followed to check sensitivity against 
cefoxitin, ciprofloxacin and gentamycin (Table I).1 The 
British Society for Antimicrobial Chemotherapy 
(BSAC) guidelines were used to check sensitivity 
against vancomycin.1 Kirby–Bauer disk diffusion 
method was used to determine the susceptibility 
pattern. Isolates resistant to Cefoxitin were recognized 
as MRSA. The data was analyzed using Statistical 
Package of Social Sciences (SPSS) version 23. 
 
Results 
Out of 194 S. aureus isolates, 128 (65.9%) were MRSA. 
Majority of Staphylococcus aureus were found in pus 
(80.4%) while urine has least number of isolates (Table 
II). Similarly, majority of MRSA was also present in 
pus (75.8%) followed by respiratory, blood, HVS and 
urine samples (Table III). All S. aureus isolates were 
tested against cefoxitin, vancomycin, gentamycin & 
ciprofloxacin. Sensitivity and resistance data of MRSA 
& methicillin sensitive Staphylococcus aureus (MSSA) 
is provided in Table IV. A majority (66%) of MRSA 
isolates were from IPD (Table V). 
 
 
 
Table I: Antibiotic concentration and zone diameter 
breakpoint used 
Antibiotic Zone diameter breakpoint 
(Resistant) 
Cefoxitin (30μg) ≤21 mm 
Ciprofloxacin (5μg) ≤15 mm 
Gentamycin (30μg) ≤12 mm 
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Table II: Distribution of S. aureus in various 
samples. 
Sample S. aureus 
(No.) 
S. aureus 
(% out of n = 194) 
Pus 156 80.4 
Respiratory 14 7.2 
Blood 11 5.7 
HVS 9 4.6 
Urine 4 2.1 
Total 194  
 
Table III: Distribution of MRSA in various samples. 
Sample MRSA 
(No.) 
MRSA 
(% of n = 128) 
Pus 97 75.8 
Respiratory 14 10.9 
Blood 9 7 
HVS 4 3.12 
Urine 4 3.12 
Total 128 99.94 
 
Table IV: Sensitivity & Resistance of MRSA & 
MSSA against Gentamycin, Vancomycin & 
Ciprofloxacin. 
Species Gentamycin 
Sensitive Resistant 
MRSA 35.7% 64.3% 
MSSA 73.3% 26.6% 
 Vancomycin 
Sensitive Resistant 
MRSA 99.1% 0.82% 
MSSA 100% 0% 
 Ciprofloxacin 
Sensitive Resistant 
MRSA 22.7% 77.3% 
MSSA 22.2% 77.7% 
 
Table V: Distribution of S. aureus & MRSA in OPD 
& IPD. 
 S. aureus MRSA 
 (%) (%) 
IPD 83.6% 66% 
OPD 16.4% 33.3% 
 
Discussion 
In 2002, Hafiz S. et al showed that prevalence of 
MRSA, in major cities of Pakistan, ranged between 2- 
61%. Same study showed that prevalence of MRSA in 
Islamabad/Rawalpindi was 46%.14 Present study 
identified 65.9% isolates as MRSA, which in 
accordance to other studies conducted in Pakistan, is 
very alarming. 
Present study showed that major source for S. aureus 
was pus which accounted for 80.4%, while respiratory, 
blood, HVS and urine samples collectively accounted 
for 19.6%. Similarly, out of 128 MRSA isolates, major 
source was pus accounting for 75.8%, while rest of the 
samples accounted for 24.14%. It is comparable to 
other studies by Ahmed K R et al7, Sumaira Kanwal et 
al 1 & Bukhari MH et al.19 Quite interestingly, this 
study showed that S. aureus isolates from respiratory 
and urine sample has more methicillin resistant strains 
than other samples. 100% of S. aureus isolated from 
respiratory and urine samples were MRSA, followed 
by 81.8%, 62.2% and 44.4% from blood, pus & HVS, 
respectively. This is contrary to the study conducted 
by Bukhari MH et al.19  
MRSA showed least sensitivity against ciprofloxacin 
i.e. 22.7%. This is in accordance to the study by Syeda 
Q. Ali et al1 & Butt T et al.17 Sensitivity against 
gentamycin was 35.7% which is in accordance with 
Butt T et alError! Bookmark not defined. and international 
studies.8,12 Sensitivity against vancomycin was 99.1%. 
One case of MRSA was found to be vancomycin 
resistant Staphylococcus aureus (VRSA). Presence of 
one VRSA case in 194 S. aureus is very alarming. 
VRSA strains are increasing steadily in Pakistan. This 
study is in accordance with the local studies.  
Distribution of S. aureus and MRSA is more in IPD 
compared to OPD (Table IV). This result is in 
accordance with local study by Ahmed K R et al.22 This 
increased distribution of MRSA in IPD can be because 
of long-term admission of patients which exposes 
them to variety of pathogens, which are able to 
transfer resistance through horizontal gene transfer.10 
 
Conclusion 
This study shows that prevalence of MRSA is 
increasing at a very alarming rate and so is its 
resistance against other antibiotics. Most worrisome is 
the fact that VRSA strains are emerging. There is an 
increase in MRSA in IPD, which should be decreased 
by keeping admittance period of the IPD patients to a 
minimum. Overuse and misuse of antibiotics by either 
self-medication or unprofessional prescriptions by 
doctors should be prevented. Improved diagnostic 
techniques can help in targeted treatment. 
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